Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2023-A00871-44 | Other Identifier | ID-RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
During deep brain stimulation procedures in Parkinson's disease (PD), the most important prognostic element is the positioning of the surgical electrode in the subthalamic nucleus which is the anatomical target. The main objective of this project is therefore to compare 2 techniques thanks to a prospective comparative randomised open-label study: the use of O-ARM to acquire stereotactic imaging directly in the operating room and the standard technique requiring stereotactic imaging to be performed in the radiology department.
Prior to electrode implantation we perform stereotactic imaging which requires the fixation of a stereotactic frame on the patient's head before imaging (Magnetic Resonance Imaging MRI / Computed Tomography CT). Currently, it is necessary to transfer the patient to the imaging department outside of the operating room after the stereotactic frame has been placed, for imaging (either MRI or CT) and then to return to the operating room to begin the electrode implantation procedure. Since 2016, the new generation O-Arm 2 allows the acquisition of stereotactic imaging with the stereotactic frame in place by increasing the field of view (40 cm versus 20 cm previously) directly in the operating room. As a result, the transfer step to the MRI and CT scanner preoperatively may no longer be necessary, and the procedure can be started more quickly with greater comfort and safety for the patient and the anaesthesia team. Several teams around the world have begun to use framed O-Arm as the gold standard for stereotactic imaging. However, no randomised controlled study has been performed to date comparing O-Arm stereotactic imaging with pre-operative CT and/or MRI reference imaging.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| O-Arm stereotactic imaging | Experimental | Imaging is performing directly in the operating room. |
|
| Standard stereotactic imaging | Active Comparator | Imaging is performing in Radiology department. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| O-Arm Stereotactic imaging | Procedure | Prior to electrode implantation, O-ARm stereotactic imaging (Magnetic Resonance Imaging) |
|
| Measure | Description | Time Frame |
|---|---|---|
| The absolute accuracy of Deep Brain Stimulation electrode implantation | The radial distance between the theoretical target and the electrode in the plane of the target regardless of the chosen trajectory (central, anterior, lateral). This distance corresponds to the minimum error between the target and the electrode. This measurement is made from the postoperative brain scan. | 48 hours |
| Measure | Description | Time Frame |
|---|---|---|
| The anatomical accuracy of Deep Brain Stimulation electrode implantation | Automatic calculation of the vector distance between the middle of pad 1 on the electrode and the theoretical target by software. | 48 hours |
| Central and alternate position of the electrodes rate |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Amaury De Barros, MD | University Hospital, Toulouse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Toulouse | Toulouse | 31000 | France |
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Standard Stereotactic imaging | Procedure | Prior to electrode implantation, standard stereotactic imaging (Magnetic Resonance Imaging) |
|
Comparison of the anatomical location of the electrode compared to the anatomical target (subthalamic nucleus) after matching preoperative Magnetic Resonance Imaging (MRI) images |
| 1 day |
| Surgical Times | Time from the end of the stereotactic frame to the surgical incision and time from the entry into room to the exit from room after generator implantation. | 1 day |
| Clinical effectiveness | Comparison of The Unified Parkinson's Disease Rating Scale (UPDRS) II, III and IV scores between baseline and 6 months and then at 6 months between the 2 groups. The UPDRS scale is composed of 47 items grouped into three parts : II, III and IV. Responses scale ranging from 0 (normal/no symptoms) to 4 (severe). | 6 months |
| Daily dose of Levodopa decrease | The change in Levodopa Equivalent Daily Dose (LEDD) before surgery and at 6 months compared between the 2 groups. This LEDD corresponds to the amount of antiparkinsonian treatments prescribed to the patient | 6 months |
| Adverse effect rate | Clinical reporting of patient events/adverse reactions | 6 months |
| Correlation between absolute accuracy and clinical effectiveness | Correlation between radial accuracy and UPDRS score for both groups | 6 months |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |